United Front Intl
No Result
View All Result
Monday, February 6, 2023
  • Login
  • Register
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • ShopNew
Contact us
United Front Intl
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • ShopNew

No products in the cart.

No Result
View All Result
United Front Intl
No Result
View All Result
Home Coronavirus

Pfizer begins testing omicron-matched COVID shots in adults

by admin
January 25, 2022
in Be in the Know, Coronavirus
Pfizer begins testing omicron-matched COVID shots in adults

FILE - Pharmacist Sima Manifar prepares a children's dose of the Pfizer COVID-19 vaccine during a vaccination clinic at City of Lawrence's "The Center," which serves seniors, families and the community, Wednesday, Dec. 29, 2021, in Lawrence, Mass. Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday, Jan. 25, 2022. (AP Photo/Charles Krupa)

Share on FacebookShare on Twitter

AP News
By LAURAN NEERGAARD

Pfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots.

Pfizer and its partner BioNTech announced the study on Tuesday.

COVID-19 vaccine-makers have been updating their shots to better match omicron in case global health authorities decide the change is needed.

Omicron is more likely than previous variants to cause infection even in people who’ve been vaccinated, but it’s not yet clear that a change to the vaccine recipe will be ordered. Among the issues regulators are weighing: Some of the first places to face an omicron surge already are seeing the mutant wane — and there’s no way to know if the next variant that arises will resemble omicron or be totally different.

The original vaccines still offer good protection against severe illness and death. Studies in the U.S. and elsewhere have made clear that adding a booster dose strengthens that protection and improves the chances of avoiding even a milder infection.

Another wrinkle in deciding whether vaccines need an update: A new U.S. report Tuesday echoes data from Britain and South Africa that omicron infections cause less severe illness — at least in part because so many people have some protection from vaccination or prior infection. During the omicron surge, 13% of hospitalized COVID-19 patients ended up in intensive care, compared with about 18% during two earlier waves, according to the Centers for Disease Control and Prevention.

Still, “we recognize the need to be prepared in the event this protection wanes over time and to potentially help address omicron and new variants in the future,” Kathrin Jansen, Pfizer’s vaccine research chief, said in a statement.

The new U.S. study will include up to 1,420 volunteers ages 18 to 55 to test the updated omicron-based shots for use as a booster or for primary vaccinations. Researchers will examine the tweaked vaccine’s safety and how it revs up the immune system in comparison to the original shots.

Full study results will take many months as volunteers receive multiple vaccine doses — and as researchers measure how long virus-fighting antibodies remain at high levels after an omicron-adapted dose versus the regular booster.

Pfizer’s CEO told CNBC earlier this month that the company could have some omicron-matched doses ready as early as March. But doing what the company calls “at-risk” manufacturing doesn’t mean those doses will be rolled out to the public. Pfizer and other vaccine makers also have brewed and tested experimental doses to match previous variants, changes that ultimately weren’t needed but offered valuable practice at tweaking the recipe.

For the new study, one group of about 600 volunteers who received two doses of the current Pfizer vaccine three to six months ago will receive either one or two omicron-based shots as boosters. Another 600 who have already gotten three regular doses of the Pfizer vaccine will be given a fourth dose of either the regular vaccine or the omicron-matched version.

The study also will enroll some unvaccinated volunteers who will receive three doses of the omicron-based vaccine.

Pfizer plans to produce 4 billion vaccine doses in 2022, and said Tuesday the amount isn’t expected to change if an omicron-adapted version is needed.

___

Associated Press writer Mike Stobbe contributed to this report.

Related

ShareTweetSendSend

Related Posts

The border buses: New York City’s migrant crisis | States of America
Videos

The border buses: New York City’s migrant crisis | States of America

January 30, 2023
What is known about new Covid variant XBB.1.5?
Coronavirus

What is known about new Covid variant XBB.1.5?

January 17, 2023
GIVING TUESDAY 2022
Be in the Know

GIVING TUESDAY 2022

November 29, 2022
Explainer: COVID, flu and RSV this U.S. winter: Why experts are worried
Coronavirus

Explainer: COVID, flu and RSV this U.S. winter: Why experts are worried

October 27, 2022
Ukrainian Refugees Arrive In Reproductive Rights Nightmare
Videos

Ukrainian Refugees Arrive In Reproductive Rights Nightmare

September 2, 2022
How Russia Profits From African Coups
Videos

How Russia Profits From African Coups

August 27, 2022

My Cart

The border buses: New York City’s migrant crisis | States of America
Videos

The border buses: New York City’s migrant crisis | States of America

by admin
January 30, 2023

Categories

  • Be in the Know
  • Coronavirus
  • Politics
  • US
  • Videos
  • World

UnitedFrontIntl Store

My Account & Ordering
Cart
Checkout
Track My Order
Refund and Returns Policy
Privacy Policy
FAQs

Site Navigation

  • Home
  • Advertise
  • Contact Us
  • Jobs
  • About Us
  • Shipping Policy

Links

CNBC
Reuters

The New York Times
The Washington Post


Your tax-deductible gift is vital and will help us fund and maintain our website to bring you current news and information on a daily basis. Thank you in advance.

© 2022 United Front Intl

No Result
View All Result
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • Contact Us
  • Advertisement
  • Shop

© 2022 United Front Intl

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In